BIOHEART-B (02185) Completes Buyback and Cancellation of 519,900 Shares Under 2022 H-Share Incentive Plan
Stock News
Aug 07
BIOHEART-B (02185) announced that on August 7, 2025, the company acquired the purchased award shares from the trustee at zero consideration, which were subsequently cancelled on the same date by the company's H-share registrar. The total number of purchased award shares bought back and cancelled represents approximately 0.21% of the company's total issued share capital before the completion of the buyback and cancellation of the purchased award shares. Immediately following the completion of the buyback and cancellation of the purchased award shares, the company's registered capital was also changed from RMB 244 million to RMB 243 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.